E D Naphazoline Phenylpherine Menthol Camphor and Hydroxypropylmethyl cellulose,Tab Olmisartan 20mg
Indian Army
PITHORAGARH, UTTARAKHAND
Bid Publish Date
14-Nov-2025, 11:38 am
Bid End Date
24-Nov-2025, 12:00 pm
EMD
₹30,000
Location
Progress
RAQuantity
23170
Category
Bromocriptine Tab
Bid Type
Two Packet Bid
The Indian Army, Department of Military Affairs, invites bids for a broad range of pharmaceutical and medical supplies (42 items listed) including injectable solutions, tablets, syrups, nasal sprays, inhalers, and IV fluids for military hospitals. Estimated value is not disclosed publicly; the project carries an EMD of ₹30,000. Location references indicate military hospital requirements at Babina Cantt with a focus on generic to branded pharma products, medical devices, and common hospital consumables. Bidders must adhere to OEM authorization, GMP/ISO standards, and drug licenses. A key differentiator is the mandatory sample submission prior to technical evaluation and the option clause to increase quantity by up to 25% at contract rates. Unique scope includes a wide assortment of formulations and device categories under a single procurement.
Pharmaceutical and medical supply categories spanning 42 items including tablets, injections, syrups, inhalers, nasal sprays, IV fluids, and topical preparations
EMD: ₹30,000; no disclosed total contract value; bids must reflect itemized quantity expectations
Mandatory OEM authorization for FY 2024-25; GMP/ISO certification; valid drug license
Samples to be submitted at Military Hospital, Babina Cantt prior to technical evaluation
Option clause allows ±25% quantity variation at contracted rates; delivery period adjustments aligned to added quantity with a minimum 30 days
EMD of ₹30,000 required with bid submission
Up to 25% quantity variation permissible during contract
Mandatory pre-award sample submission at Military Hospital, Babina Cantt
Not explicitly stated; standard government supply terms imply payment upon delivery or within 30 days of submission of compliant invoices, subject to acceptance
Delivery period governed by original delivery date; extended period calculated for added quantity with minimum 30 days
10% LD on undelivered stores as per DPM-2009; sample rejection may lead to bid rejection
Evidence of GMP/ISO certification and valid drug license
Fresh OEM authorization for FY 2024-25
Drug Inspector non-conviction certificate
Ability to supply a 42-item procurement with shelf-life comformance
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
Indian Army
PITHORAGARH, UTTARAKHAND
Indian Army
KANNUR, KERALA
Dg Armed Forces Medical Service
Indian Army
AMBALA, HARYANA
Dg Armed Forces Medical Service
GURDASPUR, PUNJAB
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | Bromocriptine Tab | Bromocriptine 2.5 mg Tab | 500 | no | manpalsinghyadav | 15 |
| 2 | Trihexyphenidyl Tab | Trihexyphenidyl HCl 2 mg Tab | 500 | no | manpalsinghyadav | 15 |
| 3 | Tab Ticagrelor 90 mg | Tab Ticagrelor 90 mg | 2,400 | no | manpalsinghyadav | 15 |
| 4 | Inj Atracurium | Inj Atracurium 10mg/ml, 2.5 ml Inj | 150 | amp | manpalsinghyadav | 15 |
| 5 | Dextrose 50 percent 25 ml Inj | Dextrose 50%, 25 ml Inj | 240 | amp | manpalsinghyadav | 15 |
| 6 | Tab Trimetazidine 35 mg MR | Tab Trimetazidine 35 mg MR | 1,800 | no | manpalsinghyadav | 15 |
| 7 | Tab Lansoprazole 15 mg | Tab Lansoprazole 15 mg | 3,000 | no | manpalsinghyadav | 15 |
| 8 | Methotrexate Tab | Methotrexate 7.5 mg Tab | 600 | no | manpalsinghyadav | 15 |
| 9 | Mifepristone and misoprostol combipack | Mifepristone and misoprostol combipack | 30 | kit | manpalsinghyadav | 15 |
| 10 | Trop T | Trop T | 100 | no | manpalsinghyadav | 15 |
| 11 | Mometasone nasal spray | Mometasone nasal spray | 60 | no | manpalsinghyadav | 15 |
| 12 | Tab Ezetimibe 10 mg | Tab Ezetimibe 10 mg | 300 | no | manpalsinghyadav | 15 |
| 13 | Tab Losartan and Hydrochlorthiazide | Tab Losartan 50 mg + Hydrochlorthiazide 12.5 mg | 600 | no | manpalsinghyadav | 15 |
| 14 | Sodium chloride 3 percent bott of 100 ml | Sodium chloride 3% bott of 100 ml | 60 | bott | manpalsinghyadav | 15 |
| 15 | Syp B Complex | Syp B Complex | 600 | bott | manpalsinghyadav | 15 |
| 16 | Normal saline zero point nine bott of 100 ml | Normal saline 0.9% bott of 100 ml | 120 | bott | manpalsinghyadav | 15 |
| 17 | Insulin Syringes 1ml | Insulin Syringes 1ml | 1,200 | no | manpalsinghyadav | 15 |
| 18 | Tab Ramipril | Tab Ramipril 2.5 mg | 600 | no | manpalsinghyadav | 15 |
| 19 | Tab Atorvastatin 40 mg | Tab Atorvastatin 40 mg | 600 | no | manpalsinghyadav | 15 |
| 20 | Syp Levocetrizine | Syp Levocetrizine 2.5mg/5ml bott of 60ml | 900 | bott | manpalsinghyadav | 15 |
| 21 | Syp Montelukast 4mg Levocetrizine Hcl | Syp Montelukast 4mg+Levocetrizine Hcl 2.5mg bott of 60ml | 1,200 | bott | manpalsinghyadav | 15 |
| 22 | Enterogermina Respules | Enterogermina Respules | 1,200 | no | manpalsinghyadav | 15 |
| 23 | Vit B12 Nasal Spray Methylcobalamine | Vit B12 Nasal Spray (Methylcobalamine) | 10 | no | manpalsinghyadav | 15 |
| 24 | Tab Saroglitazar 4 mg | Tab Saroglitazar 4 mg | 300 | no | manpalsinghyadav | 15 |
| 25 | Tab Vanoprazan 20 mg | Tab Vanoprazan 20 mg | 300 | no | manpalsinghyadav | 15 |
| 26 | Tab Cilastazole 50 mg | Tab Cilastazole 50 mg | 600 | no | manpalsinghyadav | 15 |
| 27 | Respules Levosalbutamol zero point tgree one | Respules Levosalbutamol 0.31 mg | 300 | resp | manpalsinghyadav | 15 |
| 28 | Respules Levosalbutamol zero point six three | Respules Levosalbutamol 0.63 mg | 420 | resp | manpalsinghyadav | 15 |
| 29 | Respules Levosalbutamol one point two five | Respules Levosalbutamol 1.25 mg | 300 | resp | manpalsinghyadav | 15 |
| 30 | MDI Budesonide 100 mcg | MDI Budesonide 100 mcg | 300 | no | manpalsinghyadav | 15 |
| 31 | Tab Pramipraxol | Tab Pramipraxol 0.5 mg | 500 | no | manpalsinghyadav | 15 |
| 32 | Drop Iron colloidal | Drop Iron colloidal containing Folic acid 200 mcg Iron 25 mg plus Lysine 200mg plus Vit B12 5mcg per 1 ml bott of 15ml (Tonoferon drops only ) | 600 | no | manpalsinghyadav | 15 |
| 33 | Sodium chloride inhalation respules USP 3 percent | Sodium chloride inhalation respules USP 3% w/v | 300 | spool | manpalsinghyadav | 15 |
| 34 | Oint Prilocaine and Lidocaine | Oint Prilocaine 2.5 % and Lidocaine 2.5 % | 60 | tube | manpalsinghyadav | 15 |
| 35 | Syp Phenylephrine hydrochloride and Chlorpheniramine Maleate 5 mg | Syp Phenylephrine hydrochloride 2 mg and Chlorpheniramine Maleate 5 mg for paediatric use | 400 | bott | manpalsinghyadav | 15 |
| 36 | Syp Hydroxyzine 10 mg per 5 ml for paediatric use | Syp Hydroxyzine 10 mg per 5 ml for paediatric use | 200 | bott | manpalsinghyadav | 15 |
| 37 | Aldry Lotion 20 percent w by w | Aldry Lotion 20 percent w by w | 60 | no | manpalsinghyadav | 15 |
| 38 | Syp Diastase | Syp Diastase 50 mg plus Pepsin 10 mg 200 ml syrup | 200 | bott | manpalsinghyadav | 15 |
| 39 | Multivitamin multimineral and Antioxidant syrup | Multivitamin multimineral and Antioxidant syrup containing Cholecalciferol 200 IU Pyridoxine 1 mg Niacinamide 15 mg Cyanocobalamine 1 mcg Zinc 3 mg B Carotene 28 mg Inositol 10 mg 200 ml syrup | 300 | bott | manpalsinghyadav | 15 |
| 40 | Glucostrips Accucheck Box of 50 strips | Glucostrips Accucheck Box of 50 strips | 60 | no | manpalsinghyadav | 15 |
| 41 | Cap Tacrolimus 1 mg | Cap Tacrolimus 1 mg (Only Intas mfg , Patient specific) | 600 | no | manpalsinghyadav | 15 |
| 42 | Tab Mycophenolate Mofetil 360 mg | Tab Mycophenolate Mofetil 360 mg (Only Intas mfg , Patient specific) | 600 | no | manpalsinghyadav | 15 |
GST certificate
PAN card
Experience certificates
Financial statements
EMD documents (₹30,000)
Technical bid documents
OEM authorization for FY 2024-25
GMP/ISO certificate
Copy of valid drug license
Non-conviction certificate issued by Drug Inspector
Start
25-Nov-2025, 2:00 pm
End
26-Nov-2025, 2:00 pm
Duration: 24 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
These are the final prices after the reverse auction event. Prices may be lower than initial bids.
| Rank | Seller | Final Price | Item |
|---|---|---|---|
| L1 | KANISHK MEDICO AND SURGICO(MSE,MII) Under PMA Winner | ₹8,67,995 | Item Categories : Bromocriptine Tab,Trihexyphenidyl Tab,Tab Ticagrelor 90 mg,Inj Atracurium,Dextrose 50 percent 25 ml |
| L2 | HASAN PHARMA (MSE,MII) Under PMA | ₹8,96,596 | Item Categories : Bromocriptine Tab,Trihexyphenidyl Tab,Tab Ticagrelor 90 mg,Inj Atracurium,Dextrose 50 percent 25 ml |
| L3 | MADHAV PHARMA (MSE,MII) Under PMA | ₹9,14,010 | Item Categories : Bromocriptine Tab,Trihexyphenidyl Tab,Tab Ticagrelor 90 mg,Inj Atracurium,Dextrose 50 percent 25 ml |
🎉 L1 Winner
KANISHK MEDICO AND SURGICO(MSE,MII) Under PMA
Final Price: ₹8,67,995
Key insights about UTTAR PRADESH tender market
Bidders must submit a full pharma catalog, EMD ₹30,000, OEM authorization for FY 2024-25, GMP/ISO certificates, and valid drug licenses. Samples must be delivered to Military Hospital, Babina Cantt before technical opening. Ensure 42 items alignment and adherence to delivery variation up to 25% with minimum 30 days extension.
Required documents include GST registration, PAN, experience certificates, financial statements, EMD of ₹30,000, OEM authorization for FY 2024-25, GMP/ISO certificate, valid drug license, and non-conviction certificate from Drug Inspector. Technical bid and sample submission are mandatory.
The tender lists 42 pharmaceutical and medical items across tablets, injections, syrups, inhalers, sprays, and IV solutions. Vendors must provide valid drug licenses, OEM authorizations, and GMP/ISO compliance. Exact item-wise specs are aligned to standard pharmaceutical quality and shelf-life requirements.
Delivery terms allow up to 25% quantity variation; additional time is calculated as (Additional quantity ÷ Original quantity) × Original delivery period, with a minimum of 30 days. Ensure documentation supports extended delivery as per contract terms.
The EMD required is ₹30,000. Submit the EMD along with the bid as specified in tender terms. Ensure compliance with payment instructions and correct tender form submission to avoid disqualification.
Bidder must provide fresh OEM authorization for FY 2024-25 and GMP/ISO certificates from the manufacturing company. These documents validate product authenticity, quality management, and compliance with regulatory standards for hospital-grade medications.
A 10% liquidated damages penalty applies for undelivered stores per DPM-2009. This necessitates robust supply planning and contingency measures to minimize delays while meeting the 25% quantity variation clause.
Eligibility is confirmed by GMP/ISO certification, valid drug license, OEM authorization for FY 2024-25, non-conviction Drug Inspector certificate, GST and PAN, plus demonstrate capacity to supply 42 listed items with shelf-life compliance.
Sign up now to access all documents
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS